Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

OneMedNet (ONMD) Net Income towards Common Stockholders (2022 - 2025)

OneMedNet (ONMD) has disclosed Net Income towards Common Stockholders for 4 consecutive years, with -$741000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 63.99% to -$741000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$7.8 million, a 80.22% increase, with the full-year FY2024 number at -$10.0 million, up 70.31% from a year prior.
  • Net Income towards Common Stockholders was -$741000.0 for Q3 2025 at OneMedNet, up from -$2.1 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $2.2 million in Q1 2022 to a low of -$33.4 million in Q4 2022.
  • A 4-year average of -$5.3 million and a median of -$2.1 million in 2024 define the central range for Net Income towards Common Stockholders.
  • Biggest YoY gain for Net Income towards Common Stockholders was 91.81% in 2024; the steepest drop was 48280.84% in 2024.
  • OneMedNet's Net Income towards Common Stockholders stood at -$33.4 million in 2022, then rose by 1.51% to -$32.9 million in 2023, then skyrocketed by 91.81% to -$2.7 million in 2024, then skyrocketed by 72.51% to -$741000.0 in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Net Income towards Common Stockholders are -$741000.0 (Q3 2025), -$2.1 million (Q2 2025), and -$2.3 million (Q1 2025).